Combined Gadolinium and Boron Neutron Capture Therapies for Eradication of Head-and-Neck Tumor Using Gd 10 B 6 Nanoparticles under MRI/CT Image Guidance.
Munusamy ShanmugamNaresh KuthalaXiangyi KongChi-Shiun ChiangKuo-Chu HwangPublished in: JACS Au (2023)
Eradication of head-and-neck (H&N) tumors is very difficult and challenging because of the characteristic feature of frequent recurrence and the difficulty in killing cancer stem cells. Neutron capture therapy (NCT) is emerging as a noninvasive potential modality for treatments of various types of tumors. Herein, we report that 98.5% 10 B-enriched anti-EGFR-Gd 10 B 6 nanoparticles can not only deliver large doses of 158 μg 10 B/g tumor tissues as well as 56.8 μg 157 Gd/g tumor tissues with a very high tumor-to-blood (T/B) 10 B ratio of 4.18, but also exert very effective CT/MRI image-guided combined GdBNCT effects on killing cancer stem cells and eradication of recurrent head-and-neck (H&N) tumors. This leads to a long average half-lifespan of 81 days for H&N tumor-bearing mice, which is a record-making result, and surpasses the best result reported in the literature using combined radiotherapy and T cell-mediated immunotherapy (70 d).
Keyphrases
- cancer stem cells
- contrast enhanced
- small cell lung cancer
- systematic review
- early stage
- gene expression
- deep learning
- machine learning
- squamous cell carcinoma
- type diabetes
- radiation therapy
- stem cells
- image quality
- metabolic syndrome
- epidermal growth factor receptor
- helicobacter pylori
- radiation induced
- positron emission tomography
- skeletal muscle
- tyrosine kinase
- cell therapy